Highest risk patients with clear-cell renal cell carcinoma benefit from adjuvant everolimus

Press/Media

Period	Oct 23 2023

Media coverage

Title	Highest risk patients with clear-cell renal cell carcinoma benefit from adjuvant everolimus
Media name/outlet	Newswise
Country/Territory	United States
Date	10/23/23
URL	www.newswise.com/articles/view/801304/?sc=rsla
Persons	Robert G. Uzzo